PREVENTIVE EFFECTS OF TRANSDERMAL 17-BETA-ESTRADIOL ON OSTEOPOROTIC CHANGES AFTER SURGICAL MENOPAUSE - A 2-YEAR PLACEBO-CONTROLLED TRIAL Article

FIELD, CS, ORY, SJ, WAHNER, HW et al. (1993). PREVENTIVE EFFECTS OF TRANSDERMAL 17-BETA-ESTRADIOL ON OSTEOPOROTIC CHANGES AFTER SURGICAL MENOPAUSE - A 2-YEAR PLACEBO-CONTROLLED TRIAL . AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 168(1), 114-121. 10.1016/S0002-9378(12)90897-2

cited authors

  • FIELD, CS; ORY, SJ; WAHNER, HW; HERRMANN, RR; JUDD, HL; RIGGS, BL

sustainable development goals

authors

publication date

  • January 1, 1993

published in

keywords

  • BONE-MINERAL DENSITY
  • DELAYED ONSET
  • ESTROGEN-TREATMENT
  • GLA-PROTEIN
  • HIP FRACTURE
  • LONG-TERM PREVENTION
  • Life Sciences & Biomedicine
  • OSTEOPOROSIS
  • Obstetrics & Gynecology
  • POSTMENOPAUSAL OSTEOPOROSIS
  • QUANTITATIVE COMPUTED-TOMOGRAPHY
  • RISK
  • Science & Technology
  • TRANSDERMAL 17-BETA-ESTRADIOL
  • WOMEN

Digital Object Identifier (DOI)

publisher

  • MOSBY-YEAR BOOK INC

start page

  • 114

end page

  • 121

volume

  • 168

issue

  • 1